Opposing roles of nitric oxide and rho-kinase in lipid metabolism in mice

Tohoku Journal of Experimental Medicine

Volumn 235, Issue 3, 2015, Pages 171-183

  Noda, Kazuki ^a   Godo, Shigeo ^a   Saito, Hiroki ^a   Tsutsui, Masato ^b   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Dyslipidemia; Lipid metabolism; Nitric oxide; Rho kinase

Indexed keywords

BETA ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FASUDIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RHO KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; CHOLESTEROL; SREBF2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORRELATIONAL STUDY; DYSLIPIDEMIA; ENERGY EXPENDITURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; RHO-ASSOCIATED KINASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIGLYCERIDES;

EID: 84924308562     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.235.171     Document Type: Article

References (29)

1. Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B. & Scherrer, U. (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation, 104, 342-345.
2. Hara, Y., Wakino, S., Tanabe, Y., Saito, M., Tokuyama, H., Washida, N., Tatematsu, S., Yoshioka, K., Homma, K., Hasegawa, K., Minakuchi, H., Fujimura, K., Hosoya, K., Hayashi, K., Nakayama, K., et al. (2011) Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci. Signal., 4, ra3.
3. Kanazawa, I., Yamaguchi, T., Yano, S., Yamauchi, M. & Sugimoto, T. (2009) Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression. Am. J. Physiol. Endocrinol. Metab., 296, E139-146.
4. Kato, M., Blanton, R., Wang, G.R., Judson, T.J., Abe, Y., Myoishi, M., Karas, R.H. & Mendelsohn, M.E. (2012) Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα. J. Biol. Chem., 287, 41342-41351.
5. Kikuchi, Y., Yamada, M., Imakiire, T., Kushiyama, T., Higashi, K., Hyodo, N., Yamamoto, K., Oda, T., Suzuki, S. & Miura, S. (2007) A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. J. Endocrinol., 192, 595-603.
6. Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J.Y., Gao, B., Wierzbicki, M., Verbeuren, T.J., Shaw, R.J., Cohen, R.A., et al. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab., 13, 376-388.
7. Lim, S., Despres, J.P. & Koh, K.K. (2011) Prevention of atherosclerosis in overweight/obese patients: in need of novel multitargeted approaches. Circ. J., 75, 1019-1027.
8. Liu, P.Y., Chen, J.H., Lin, L.J. & Liao, J.K. (2007) Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J. Am. Coll. Cardiol., 49, 1619-1624.
9. Monti, L.D., Barlassina, C., Citterio, L., Galluccio, E., Berzuini, C., Setola, E., Valsecchi, G., Lucotti, P., Pozza, G., Bernardinelli, L., Casari, G. & Piatti, P. (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes, 52, 1270-1275.
10. Mora, S., Glynn, R.J. & Ridker, P.M. (2013) High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation, 128, 1189-1197.
11. Morishita, T., Tsutsui, M., Shimokawa, H., Sabanai, K., Tasaki, H., Suda, O., Nakata, S., Tanimoto, A., Wang, K.Y. & Ueta, Y. (2005) Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc. Natl. Acad. Sci. USA, 102, 10616-10621.
12. Nakata, S., Tsutsui, M., Shimokawa, H., Suda, O., Morishita, T., Shibata, K., Yatera, Y., Sabanai, K., Tanimoto, A., Nagasaki, M., Tasaki, H., Sasaguri, Y., Nakashima, Y., Otsuji, Y. & Yanagihara, N. (2008) Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 117, 2211-2223.
13. Noda, K., Hosoya, M., Nakajima, S., Ohashi, J., Fukumoto, Y. & Shimokawa, H. (2012) Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice. Tohoku J. Exp. Med., 228, 305-315.
14. Noda, K., Nakajima, S., Godo, S., Saito, H., Ikeda, S., Shimizu, T., Enkhjargal, B., Fukumoto, Y., Tsukita, S., Yamada, T., Katagiri, H. & Shimokawa, H. (2014) Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice. PloS One, 9, e110446.
15. Pedersen, B.K. & Febbraio, M.A. (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol., 8, 457-465.
16. Sansbury, B.E., Cummins, T.D., Tang, Y., Hellmann, J., Holden, C.R., Harbeson, M.A., Chen, Y., Patel, R.P., Spite, M., Bhatnagar, A. & Hill, B.G. (2012) Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ. Res., 111, 1176-1189.
17. Sauzeau, V., Rolli-Derkinderen, M., Marionneau, C., Loirand, G. & Pacaud, P. (2003) RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J. Biol. Chem., 278, 9472-9480.
18. Shimizu, T., Fukumoto, Y., Tanaka, S., Satoh, K., Ikeda, S. & Shimokawa, H. (2013) Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice. Arterioscler. Thromb. Vasc. Biol., 33, 2780- 2791.
19. Shimokawa, H. (1999) Primary endothelial dysfunction: atherosclerosis. J. Mol. Cell. Cardiol., 31, 23-37.
20. Shimokawa, H., Morishige, K., Miyata, K., Kandabashi, T., Eto, Y., Ikegaki, I., Asano, T., Kaibuchi, K. & Takeshita, A. (2001) Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc. Res., 51, 169-177.
21. Shimokawa, H. & Takeshita, A. (2005) Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler. Thromb. Vasc. Biol., 25, 1767-1775.
22. Suda, O., Tsutsui, M., Morishita, T., Tanimoto, A., Horiuchi, M., Tasaki, H., Huang, P.L., Sasaguri, Y., Yanagihara, N. & Nakashima, Y. (2002) Long-term treatment with N(ω)-nitro- L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation, 106, 1729-1735.
23. Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H. & Liao, J.K. (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation, 106, 57-62.
24. Uno, K., Katagiri, H., Yamada, T., Ishigaki, Y., Ogihara, T., Imai, J., Hasegawa, Y., Gao, J., Kaneko, K., Iwasaki, H., Ishihara, H., Sasano, H., Inukai, K., Mizuguchi, H., Asano, T., et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science, 312, 1656-1659.
25. Usui, S., Hara, Y., Hosaki, S. & Okazaki, M. (2002) A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res., 43, 805-814.
26. Vanhoutte, P.M. (2009) Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ. J., 73, 595-601.
27. Viollet, B., Andreelli, F., Jorgensen, S.B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., Gomas, E., Nicolas, G., Wojtaszewski, J.F., Kahn, A., Carling, D., et al. (2003) The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest., 111, 91-98.
28. Wolfrum, S., Dendorfer, A., Rikitake, Y., Stalker, T.J., Gong, Y., Scalia, R., Dominiak, P. & Liao, J.K. (2004) Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler. Thromb. Vasc. Biol., 24, 1842-1847.
29. Yatera, Y., Shibata, K., Furuno, Y., Sabanai, K., Morisada, N., Nakata, S., Morishita, T., Toyohira, Y., Wang, K.Y., Tanimoto, A., Sasaguri, Y., Tasaki, H., Nakashima, Y., Shimokawa, H., Yanagihara, N., et al. (2010) Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet. Cardiovasc. Res., 87, 675-682.